Navigation Links
First Arizona 'Strides for Life' event nets $25,000 for TGen research
Date:5/28/2010

PHOENIX, Ariz. May 28, 2010 Following its first major Arizona fundraising event, the national Lung Cancer Research Foundation will donate $25,000 for lung cancer studies at the Translational Genomics Research Institute (TGen).

The first Strides for Life-Arizona event, held April 11 near Tempe Town Lake, drew 175 participants to a family-friendly 3-mile fun run-walk and children's dash.

It was so successful, the New York-based Lung Cancer Research Foundation already has scheduled its 2nd annual Arizona fundraiser at the same location, Tempe Arts Park, at 7:30 a.m. April 10, 2011.

"We were thrilled with the turnout and success of our inaugural Strides for Life Arizona," said Laurie C. Carson, the Founder and President of the Lung Cancer Research Foundation. "LCRF would never have been able to accomplish our initial goal and establish a footprint for this event without the encouragement and support that TGen provided. It is an honor and a privilege to be affiliated and to support their groundbreaking biomedical research in lung cancer."

Lung cancer is the leading cause of cancer death worldwide, annually killing 1.3 million people. Nearly 220,000 new cases of lung cancer will be diagnosed this year in the U.S., where more than 159,000 men and women will die from the disease, according to estimates by the National Cancer Institute.

There remains no practical way to screen for lung cancer. As a result, nearly 75 percent of patients are diagnosed with advanced-stage disease, leaving few options for treatment. Among American women, lung cancer is responsible for more cancer deaths than breast cancer and all gynecological cancers, combined. And while the link between smoking and lung cancer is well established, nearly 50 percent of new lung cancer cases are former smokers and about 15 percent have never smoked.

TGen's Lung Cancer Research Lab is at the forefront of efforts to improve lung cancer detection, develop new therapies and enhance our understanding of tumor biology.

TGen Foundation President Michael Bassoff said the $25,000 donation by the Lung Cancer Research Foundation would be applied immediately to support TGen's lung cancer research.

"We are thrilled at the initial success of Strides for Life-Arizona, and we are extremely grateful and honored to have merited the support of such a remarkably dedicated partner-in-science as Laurie Carson and the Lung Cancer Research Foundation," Bassoff said. "The gift from LCRF will support scientific research in an area that affects more cancer patients than any other type of cancer."

LCRF, a leader in helping advance the pace of lung cancer research, previously awarded $75,000 to TGen to name the Lung Cancer Research Foundation Bench, which enables TGen scientists to conduct groundbreaking scientific investigations.


'/>"/>

Contact: Steve Yozwiak
syozwiak@tgen.org
602-343-8704
The Translational Genomics Research Institute
Source:Eurekalert

Related biology news :

1. First horned dinosaur from Mexico
2. American Sociological Association launches first-of-its-kind teaching tool
3. New study first to directly measure body temperatures of extinct species
4. Spitting cobras track first, predict later
5. BIO-key(R) Reports First Quarter 2010 Financial Results
6. Researchers offer first proof that chemicals from seaweeds damage coral on contact
7. Suzanne Cory becomes first-elected woman president of AAS
8. Sequencing of first frog genome sheds light on treating disease
9. Linnaeus 2.0: First E-publication of new plant species
10. First course of veggies may appeal to hungry preschoolers
11. First X-ray lasers early success brings approval for next-phase facility
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:3/6/2017)... SAN MATEO, Calif. , March 6, 2017 ... predictive marketing and sales technology, today announced Predictive ... (AI) solution for infusing actionable sales intelligence into ... customers to automatically enable their sales organizations with ... contextual messages that allow for intelligent engagement. Predictive ...
(Date:3/2/2017)... Summary This report provides all ... and its partnering interests and activities since 2010. ... The Partnering Deals and Alliance since 2010 report provides ... of the world,s leading life sciences companies. ... ensure inclusion of the most up to date deal ...
(Date:3/2/2017)... , March 2, 2017 Australian stem ... (ASX: CYP), has signed an agreement with the ... the Monash Biomedicine Discovery Institute and Department of Pharmacology ... conduct a further preclinical study to support the use ... of asthma.  Asthma is a chronic, ...
Breaking Biology News(10 mins):
(Date:3/23/2017)... , March 23, 2017 Kineta, ... development of novel therapies in immuno-oncology, today announced ... lead" small molecule compounds that activate interferon response ... pathways and demonstrate immune-mediated tumor regression in a ... the study who demonstrated complete tumor regression to ...
(Date:3/23/2017)... , March 23, 2017 According to a ... and derivatives market is fragmented due to the presence of a large ... Proliant, Thermo Fisher , and Sigma-Aldrich, compete with each other ... companies, collectively, held more than 76% of this market in 2016.  ... As of now, ...
(Date:3/23/2017)... , March 23, 2017 In ... four equities in the Biotech industry: Sangamo Therapeutics Inc. ... Inc. (NYSE MKT: SYN), and Regulus Therapeutics Inc. (NASDAQ: ... , 2017, Credit Suisse upgraded its rating on Pharmaceuticals/Biotechnology to "Overweight" from ... their free report at: ...
(Date:3/22/2017)... 22, 2017 Regeneron Pharmaceuticals, Inc. (NASDAQ: REGN), today ... (RGC), U.K. Biobank and GSK to generate genetic sequence data ... The initiative will enable researchers to gain valuable insights to ... wide range of serious and life threatening diseases. ... Genetic evidence ...
Breaking Biology Technology: